Roche Holding AG

Type: Company
Name: Roche Holding AG (Roche Holding Ltd)
Nationality: Switzerland
Web Address: http://www.roche.com/
Fact Sheet: Fact Sheet for Roche Holding AG
First reported 8 hours ago - Updated 31 mins ago - 8 reports

UPDATE 1-EU medicines agency warns of stolen Roche cancer drug

(Adds Roche statement, details)LONDON, April 16 (Reuters) - The European Medicines Agency warned on Wednesday that vials of Roche's breast cancer drug Herceptin, thought to have been stolen from ... ... [Published Big News Network - 31 mins ago]
First reported 11 hours ago - Updated 2 hours ago - 4 reports

Roche Reaffirms Full Year Outlook But Suffers From Currency Movements (publish today)

Roche Holdings (OTC:RHHBY) recently released its Q1 2014 results and reported a slight decline of 1% in its revenues. [] However, this decline is primarily attributable to the strengthening of Swiss Franc against major currencies such as U.S. Dollar and ... [Published Trefis - 2 hours ago]
First reported 5 hours ago - Updated 3 hours ago - 2 reports

EMA warns Herceptin vials stolen in Italy spreading through EU

Vials of Roche's cancer med Herceptin that were stolen in Italy are now showing up in other places in Europe, leading the European Medicines Agency (EMA) to issue an alert and Herceptin maker Roche to recall all of the batches from which the stolen drugs ... [Published FiercePharma - 3 hours ago]
First reported 9 hours ago - Updated 8 hours ago - 2 reports

Research and Markets: Global Companion Diagnostics Market 2014-2018 with Abbott Laboratories, Agilent Technologies, bioMrieux SA, Qiagen N.V. & Roche Holding Dominating

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/84cgmr/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering. The Global Companion Diagnostics ... [Published Business Wire Health News - 8 hours ago]
First reported Apr 15 2014 - Updated 11 hours ago - 2 reports

Sales of cancer drugs soar once again at Roche

Related Biotechnology, Pharmaceutical and Healthcare News Original Article: Sales of cancer drugs soar once again at RocheNEXT ARTICLE More From BioPortfolio on "Sales of cancer drugs soar once again at Roche"Search BioPortfolio ... [Published BioPortfolio - 11 hours ago]
First reported Apr 15 2014 - Updated Apr 15 2014 - 14 reports

This Forgotten Pharma Could Be a Hit for Your Portfolio

Within the world of Big Pharma,  Roche ( NASDAQOTH: RHHBY     ) offers a pretty compelling mix. Not only does Roche have one of the strongest oncology platforms today, it also offers one of the deepest pipelines. The company's non-oncology pipeline is ... [Published Motley Fool Discussion Boards - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 3 reports

Strong franc hurts Roche but cancer drugs fight back

| SCRIPIn the first of the big pharma first-quarter earnings announcements, Roche has reported that its pharma sales have climbed 4% at constant exchange rates (-1% in Swiss francs) with continued growth of Avastin, MabThera/Rituxan, Actemra/RoActemra ... [Published BioPortfolio - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 2 reports

Scientists say UK wasted £560m on flu drugs that are not proven

© Bloomberg/GettyRoche HQ: the company disputes a report by independent scientists questioning the effectiveness of TamifluThe government has wasted half a billion pounds stockpiling two anti- flu drugs that have not been proved to stop the spread of ... [Published Sott.net - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 8 reports

Roche may face EU levies following drug safety breaches

Roche faces a potential $740 million fine from the European Commission after its regulator found a series of pharmacovigilance failures.In 2012 the European Medicines Agency began investigating Roche after ‘deficiencies’ in the manufacturer’s pharmacovigilance ... [Published Pharmafocus - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 4 reports

New cancer drugs limit Roche first-quarter sales drop

A strong uptake of new cancer medicines helped Roche to limit a decline in first-quarter sales and the Swiss company confirmed a forecast for higher earnings this year. Roche Holding AG said currency movements, the loss of exclusivity on chemotherapy ... [Published KiniBiz - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 2 reports

BRIEF-Roche shares rise 1.5 pct after Q1 results

Roche Holding AG :* Shares rise 1.5 percent after Q1 results ZURICH, April 15 ... [Published Reuters - Apr 15 2014]
Entities: Roche Holding AG
First reported Apr 14 2014 - Updated Apr 14 2014 - 2 reports

France May Approve Biosimilar Substitution

According to a story in Fierce Pharma, France may approve a measure to allow substitution with biosimilars. If this is enacted, then France will become the first European nation to allow this. Needless to say, Big Pharma players like Sanofi, Roche an ... [Published BioPortfolio - Apr 14 2014]

Quotes

...aggressive approach to this revenue-loss problem," said Kolodziej, adding he would have "personally preferred" to let the budget stand as proposed. "We could tighten our belts to save money over the course of the year and then use that savings to offset Roche."
"Novartis pulling out is an exemplar of Big Pharma not being able to innovate, and historically they have never been able to innovate" he continued
Europeans " are now willing to take jobs at less than they were willing to work for three or four years ago, in some cases 30% to 40% less, " said Mr. Browne, pointing to Europe's high unemployment rates and big drops in wages in some countries
...Some of the packages of powder have liquid in them and "evidence of tampering with the rubber stoppers, crimping caps or lids" was visible on some

More Content

All (1712) | News (1533) | Reports (1) | Blogs (123) | Audio/Video (0) | Fact Sheets (27) | Press Releases (26)
sort by: Date | Relevance
Addition of bevacizumab to chemotherapy improve... [Published Orthopedics Today - 22 mins ago]
UPDATE 1-EU medicines agency warns of stolen Ro... [Published Big News Network - 31 mins ago]
Clifton taxpayers face $17 tax hike [Published North Jersey.com - 36 mins ago]
Market Report, "CountryFocus: Healthcare, Regul... [Published Digital Journal - 57 mins ago]
FDA considers controversial HPV test alternativ... [Published SCPR - 1 hour ago]
Healthcare Review: Verde Media Group, Apricus B... [Published BioMedReports - 1 hour ago]
MHRA appoints new Director of Licensing [Published Pharma Field - 1 hour ago]
Thomson Reuters Forecasts Leading Drugs To Watc... [Published Pharmaceutical Online - 2 hours ago]
Alnylam COO on Novartis RNAi pullout: Big Pharm... [Published Fierce Drug Delivery - 2 hours ago]
Acute Myelocytic Leukemia (AML, Acute Myeloblas... [Published SBWire - 2 hours ago]
Roche Reaffirms Full Year Outlook But Suffers F... [Published Trefis - 2 hours ago]
The Future of Clinical Data Sharing is Taking S... [Published eClinical Trends - 2 hours ago]
Mealey's IP/Tech - Federal Circuit Affirms: Os... [Published Mealey - 3 hours ago]
Why Are Developed European Equities Are Attract... [Published Seeking Alpha - 3 hours ago]
EMA warns Herceptin vials stolen in Italy sprea... [Published FiercePharma - 3 hours ago]
Tamiflu scandal exposes bloodsucking big pharma [Published Socialist Party - 3 hours ago]
Concise Analysis of the International Molecular... [Published Yahoo! Finance - 3 hours ago]
Dumaguing: How Safe Are Diet Pills? [Published Sun Star Network - 4 hours ago]
Fitch Affirms Roche at 'AA'; Outlook Stable [Published Reuters - 4 hours ago]
EMA warns about falsifed Herceptin [Published Pharma Times - 5 hours ago]
Boehringer Ingelheim Corporation To Open Trial ... [Published BioSpace - 5 hours ago]
Why Lpath Could Rise 300% [Published 24/7 Wall St - 5 hours ago]
Rheumatoid Arthritis - Pipeline Review, H1 2014... [Published Digital Journal - 5 hours ago]
Zalicus to fold into Boston-based Epirus [Published Seeking Alpha - 5 hours ago]
Stolen Roche Cancer Drug on Market [Published WSJ.com: What's News Europe - 6 hours ago]
Study Questions Tamiflu's Effectiveness [Published FOX47News - 6 hours ago]
Governments should review use of ‘stockpiled’ f... [Published Irish Medical Times - 6 hours ago]
True Grit: Why pharma’s leaders aren’t yet capable [Published MedCity News - 6 hours ago]
Stolen Vials of Cancer Drug Reintroduced as Cou... [Published Bloomberg - 6 hours ago]
BRIEFEU medicines agency warns of stolen Roche ... [Published BioPortfolio - 6 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Future of Clinical Data Sharing is Taking S... [Published eClinical Trends - 2 hours ago]
Amazing!!  For profit, companies are recognizing that it’s in their interest to share data. It only takes some careful planning to protect their assets.  The extremely high cost of drug R&D has now made it clear that collaboration is necessary to ...
Research and Markets: Global Companion Diagnost... [Published Business Wire Health News - 8 hours ago]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/84cgmr/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering. The Global Companion Diagnostics ...
Futures Ignore Overnight Newsflow, Prepare For ... [Published Zero Hedge - Apr 15 2014]
One can see that while the traditional 6:00 AM USDJPY buy program is just duying to resume aggressive upward momentum ignition, futures are still leery and confused by the recent post-open high beta selloffs. Then again, things like yesterday's ridiculous ...
UPDATE 2-New cancer drugs limit Roche first-qua... [Published AdBanks.net - Apr 15 2014]
* Q1 sales 11.496 bln Swiss francs vs 11.887 bln forecast * Hit by weak U.S. dollar, yen, LatAm currencies * Confirms full-year guidance for higher sales and profits * Shares outperform sector (Adds CFO comment, analyst, shares, details ...
Roche's Breast-Cancer Drug Sales Surge, Led by ... [Published Bloomberg via Google News - Apr 15 2014]
Roche's Breast-Cancer Drug Sales Surge, Led by Perjeta Bloomberg As of yesterday, Roche shares had returned 13 percent in the past year including reinvested dividends, compared with 11 percent for the Bloomberg Europe Pharmaceutical Index. The ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
BNY Mellon and OTC Markets Group Launch OTCQX(R... [Published OTC Markets Group Corporate News - Apr 09 2014]
Genentech and PatientsLikeMe Enter Patient-Cent... [Published PatientsLikeMe Press Release - Apr 07 2014]
Jury to Roche: You Failed to Properly Warn Phys... [Published GlobeNewswire: Advertising News - Mar 11 2014]
Former Roche Pharmaceuticals CEO Joins Mesoblas... [Published GlobeNewswire: Acquisitions News - Mar 06 2014]
OTCM ADR Index Rose 5.3% in Fourth Quarter, 18.... [Published OTC Markets Group Corporate News - Mar 04 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.